PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arth

Study Overview ; Conditions · Psoriatic Arthritis ; Intervention / Treatment · Drug: Apremilast 20mg · Drug: Apremilast 30mg · Drug: Placebo + 20 mg Apremilast · Drug: Placebo + 30 mg Apremilast

Canakinumab in the Treatment of Acute Gout Flares and Prevention of New Flares i

The purpose of this study was to demonstrate that canakinumab given upon acute gout flares relieves the signs and symptoms and prevents recurrence of gout flares in patients with frequent flares of gout for whom non-steroidal anti-inflammatory drugs (NSAIDs) and/ or colchicine are contraindicated, not tolerated, or ineffective. The efficacy of canakinumab was compared to the corticosteroid triamcinolone acetonide. The purpose of the first 12 week extension study was to collect additional safety, tolerability and efficacy data in patients who ha ...

OVERVIEW OF FTC ACTIONS IN HEALTH CARE SERVICES AND PRODUCTS

OVERVIEW OF FTC ACTIONS IN HEALTH CARE SERVICES AND PRODUCTS Health Care Division Bureau of Competition Federal Trade Commission Washington D.C. 20580 Bradley S. Albert Acting Assistant...

About Us | CopyMasters

Hickory Springs Manufacturing · Unifour Anesthesia and Pain Treatment Physicians · Accessory Exchange · Richelieu · Chad Austin, Inc. Hotstick USA · Mitchell Gold + Bob Williams · Frye Regional Medical Center · Lee Industries · Swisher Internal · Women’s Clinic · Southern Imaging (S.I. Solutions)